News

AmKor Pharma (AmKor) and Hengdian Group (Hengdian) have entered into a licensing agreement for further development and commercialisation of Neu2000 in China. As per the terms of the

Genevac has announced the Puck, launched in 2008, will simultaneously accommodate up to eighteen 60ml Accelerated Solvent Extractor (ASE) tubes. Puck is a new sampling accessory that extends

BeamOne is planning to establish its new electron beam medical device sterilisation service center in the Pittsburgh, PA. Reportedly the inauguration is expected to begin on the new

Beardsworth has selected OmniComm Systems’ (OmniComm) TrialMaster EDC solution for conducting a Phase II vaccine study. The three-year, ten-site study is planning to enroll 340 subjects. OmniComm and

Pharmasset has announced that the enrollment of Cohort 2, led by Roche, will continue for the remaining 300 genotype 1 and 4 patients in the ongoing phase 2b

Astellas will install PAS-X at its production site in Meppel. PAS-X is an EBR (Electronic Batch Recording). PAS-X will be installed at the company’s pharmaceutical solids production and

The Drug Controller General of India (DCGI) will soon implement the e-governance model adopted by Food and Drug Control Administration (FDCA), Gujarat, India, in the Central Drug Standard

Health Canada has issued a warning relating to possible manufacturing problems with Caninsulin. Caninsulin is a drug aimed at treatment of diabetes in dogs and cats. Health Canada

i3 has entered into an agreement with Acurian, to provide study sponsors with a solution to recruit investigators for clinical trials. Acurian’s patient database will be complemented by